INHERIT EGFR - Studying Germline EGFR Mutations
Clinical trial NCT01754025 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT01754025
- Sponsor
- Dana-Farber Cancer Institute
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2012-12-28
- Primary completion
- 2018-11-07
- Enrollment
- 121
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.